Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy-Reference-Cited by-同舟云学术

Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy

Published:2013-11 Issue:11 Volume:24 Page:2881-2886
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Schweizer M.T.,Zhou X.C.,Wang H.,Yang T.,Shaukat F.,Partin A.W.,Eisenberger M.A.,Antonarakis E.S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/11/2881/16701079/mdt335.pdf

Reference24 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results;Roehl;J Urol,2004

3. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

4. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up;Antonarakis;BJU Int,2012

5. Assessing and treating patients with increasing prostate specific antigen following radical prostatectomy;Sandler;J Urol,2007

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic ablative radiation therapy in metastatic prostate cancer;Current Opinion in Oncology;2024-02-15

2. Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol;Clinical and Translational Radiation Oncology;2023-05

3. SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?;BMC Cancer;2022-12-12

4. First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature;European Urology Oncology;2022-08

5. Oligometastatic disease in biochemical recurrence of prostate cancer: Prevalence on PSMA PET/CT and consecutive metastasis-directed therapy – Experience at a tertiary referral center;Nuklearmedizin - NuclearMedicine;2022-04-06